Other: Sham procedure ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	1

90. 網膜色素変性症

---

臨床試験数 : 130 /  薬物数 : 180 - (DrugBank : 41) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 109

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04123626 (ClinicalTrials.gov)	October 7, 2019	1/10/2019	A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene	A Prospective First-In-Human Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa (adRP) Due to the P23H Mutation in the RHO Gene	Autosomal Dominant Retinitis Pigmentosa;Eye Diseases;Eye Diseases, Hereditary;Retinal Dystrophies;Retinal Disease;Retinitis;Vision Tunnel;Vision Disorders	Drug: QR-1123;Other: Sham procedure	ProQR Therapeutics	NULL	Recruiting	18 Years	N/A	All	35	Phase 1/Phase 2	United States